feed,title,long_url,short_url
Benzinga,Unicycive Shares Jump As Renazorb Achieves Primary Endpoint In Bioequivalence Study,https://benzinga.com/general/biotech/22/12/30214070/unicycive-shares-jump-as-renazorb-achieves-primary-endpoint-in-bioequivalence-study,https://da.gd/C9uQL
